目的:探讨低钙透析液针对低转运性骨病患者PTH、BGP的影响以及和骨质疏松、血管钙化两大症状的联系.方法:随机抽取2021年9月至2022年9月于我院肾性骨病接受医疗措施的患者80例作为参考对象.根据患者病史、骨病类型、年龄、性别、治疗历史等指标结合数量指标,按照人数、治疗阶段两大标准将患者均分为观察组、对照组.观察组患者阶段重点采用低钙透析液进行治疗;对照组阶段为采用低钙透析液治疗之前.对比两阶段患者后期肾功能指标;此外统计并对比两阶段患者在BGP、PTH、BMD、CACS、Wnt1、β-catenin

Objective The purpose of cefodizime in treatment of senile bacterial pneumonia in safety and efficacy evaluation.Methods A retrospective analysis of 100 cases of senile bacterial pneumonia patients with simple randomization were randomly divided into 50 cases in the control group (ceftazidime treatment),50 cases in observation group (cefodizime in treatment),statistics,analysis and comparison of two groups before and after treatment the levels of white blood cell changes,after treatment,the cure rate of sputum culture negative time,significantly efficiency,effectiveness and the incidence of adverse reaction.Results The two groups before treatment of white blood cell (t=3.12,P<0.05,no significant difference after treatment),white blood cell (t=5.12,P<0.05,with significant difference between two groups after treatment),sputum culture negative time (t=4.77,P<0.05,with significant difference),the cure rate,significant efficiency,the efficiency and the incidence of adverse reactions compared (χ2=4.67,4.77,5.12,4.98,P<0.05,with significant difference).Conclusion Cefodizime in treatment of bacterial pneumonia in the elderly is safe,effective than other drugs.